Policy and Advocacy
Supportive Care for People Affected By Cancer: Report
On the occasion of the European Cancer Nursing Day on Friday 18 May, the European Cancer Patient Coalition and the European Oncology Nursing Society have published the report on Supportive Care for people affected by cancer. The report is the outcome of the Round Table held in February, which was held jointly together with MEP Lieve Wierinck (ALDE, Belgium).
“The cancer care team are the front runners in informing patients as well about the side effects of cancer treatment, a treatment which can harm the healthy tissues in our bodies. Some of those side effects are for example nausea and vomiting, which remain an important adverse effect of treatment, and occur more often in younger people.” MEP Lieve Wierinck.
Supportive care is the prevention and management of the symptoms of cancer and its treatment from diagnosis to the end of life. It includes support for people with cancer, their families, and their carers. Supportive care for people with cancer is pivotal for rehabilitation, secondary cancer prevention, survivorship and end-of-life care.
The Round Table and report promote the importance of supportive care and cancer nurses in Europe, with a particular focus on cancer-associated thrombosis as well as chemotherapy induced nausea and vomiting.
For people with cancer, supportive care is vital. The report identifies the main challenges and solutions for improving supportive care for people with cancer, and delivers a five-point call for action:
- Policy-makers, patient groups and nursing groups should collaborate to develop specific training exchange programmes in oncology for nurses during their education.
- Patient and nursing groups, through the support of Members of the European Parliament and Members of National Parliaments, should continue to inform their communities about the importance of supportive care.
- Patient and nursing societies should raise further awareness on cancer-associated thrombosis as well as chemotherapy-induced nausea and vomiting, and collaborate with policy-makers to ensure further investment into primary and secondary prevention of these and other conditions.
- Stakeholders should advocate for the recognition of nurses’ specialisations both at European and national levels, and for the further communication skills training for oncology nurses.
- The European Commission should consider cancer-associated thrombosis as well as chemotherapy-induced nausea and vomiting as key indicators in good cancer care and health system performance reviews.